Elevance Health Cash on Hand 2010-2025 | ELV
Elevance Health cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Elevance Health cash on hand for the quarter ending March 31, 2025 was $33.652B, a 7.21% decline year-over-year.
- Elevance Health cash on hand for 2024 was $34.681B, a 4.64% decline from 2023.
- Elevance Health cash on hand for 2023 was $36.369B, a 6.06% increase from 2022.
- Elevance Health cash on hand for 2022 was $34.292B, a 3.83% increase from 2021.
| Elevance Health Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $34,681 |
| 2023 | $36,369 |
| 2022 | $34,292 |
| 2021 | $33,028 |
| 2020 | $30,733 |
| 2019 | $25,622 |
| 2018 | $22,744 |
| 2017 | $25,057 |
| 2016 | $23,803 |
| 2015 | $21,795 |
| 2014 | $23,061 |
| 2013 | $21,342 |
| 2012 | $21,180 |
| 2011 | $20,189 |
| 2010 | $20,016 |
| 2009 | $21,945 |
| Elevance Health Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $33,652 |
| 2024-12-31 | $34,681 |
| 2024-09-30 | $37,933 |
| 2024-06-30 | $35,991 |
| 2024-03-31 | $36,267 |
| 2023-12-31 | $36,369 |
| 2023-09-30 | $38,895 |
| 2023-06-30 | $38,284 |
| 2023-03-31 | $38,170 |
| 2022-12-31 | $34,292 |
| 2022-09-30 | $35,901 |
| 2022-06-30 | $33,793 |
| 2022-03-31 | $34,042 |
| 2021-12-31 | $33,028 |
| 2021-09-30 | $33,957 |
| 2021-06-30 | $32,852 |
| 2021-03-31 | $37,511 |
| 2020-12-31 | $30,733 |
| 2020-09-30 | $29,766 |
| 2020-06-30 | $31,516 |
| 2020-03-31 | $25,796 |
| 2019-12-31 | $25,622 |
| 2019-09-30 | $26,925 |
| 2019-06-30 | $25,272 |
| 2019-03-31 | $24,099 |
| 2018-12-31 | $22,744 |
| 2018-09-30 | $24,684 |
| 2018-06-30 | $24,847 |
| 2018-03-31 | $24,701 |
| 2017-12-31 | $25,057 |
| 2017-09-30 | $27,171 |
| 2017-06-30 | $26,567 |
| 2017-03-31 | $27,790 |
| 2016-12-31 | $23,803 |
| 2016-09-30 | $23,619 |
| 2016-06-30 | $23,311 |
| 2016-03-31 | $23,100 |
| 2015-12-31 | $21,795 |
| 2015-09-30 | $22,497 |
| 2015-06-30 | $23,237 |
| 2015-03-31 | $24,354 |
| 2014-12-31 | $23,061 |
| 2014-09-30 | $23,569 |
| 2014-06-30 | $23,972 |
| 2014-03-31 | $23,290 |
| 2013-12-31 | $21,342 |
| 2013-09-30 | $22,061 |
| 2013-06-30 | $21,123 |
| 2013-03-31 | $21,434 |
| 2012-12-31 | $21,180 |
| 2012-09-30 | $22,833 |
| 2012-06-30 | $21,081 |
| 2012-03-31 | $20,437 |
| 2011-12-31 | $20,189 |
| 2011-09-30 | $20,940 |
| 2011-06-30 | $20,369 |
| 2011-03-31 | $20,332 |
| 2010-12-31 | $20,016 |
| 2010-09-30 | $20,964 |
| 2010-06-30 | $19,320 |
| 2010-03-31 | $20,804 |
| 2009-12-31 | $21,945 |
| 2009-09-30 | $18,605 |
| 2009-06-30 | $17,684 |
| 2009-03-31 | $5,441 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $78.142B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.077B | 27.58 |
| CVS Health (CVS) | United States | $83.011B | 10.32 |
| Cencora (COR) | United States | $57.628B | 20.05 |
| DiDi Global (DIDIY) | China | $23.768B | 25.25 |
| Natera (NTRA) | United States | $22.306B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.229B | 17.22 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.751B | 0.00 |
| Solventum (SOLV) | United States | $13.128B | 13.90 |
| CochLear (CHEOY) | Australia | $12.788B | 0.00 |
| ICON (ICLR) | Ireland | $12.281B | 11.42 |
| Revvity (RVTY) | United States | $12.070B | 20.77 |
| Viatris (VTRS) | United States | $10.857B | 3.73 |
| Medpace Holdings (MEDP) | United States | $9.434B | 25.06 |
| Avantor (AVTR) | United States | $9.336B | 13.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.582B | 0.00 |
| HealthEquity (HQY) | United States | $8.405B | 36.81 |
| Charles River Laboratories (CRL) | United States | $8.038B | 15.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.772B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.024B | 29.58 |
| BrightSpring Health Services (BTSG) | United States | $3.667B | 33.65 |
| Sotera Health (SHC) | United States | $3.375B | 19.18 |
| Surgery Partners (SGRY) | United States | $2.855B | 37.12 |
| Alignment Healthcare (ALHC) | United States | $2.647B | 0.00 |
| Concentras Parent (CON) | United States | $2.621B | 15.15 |
| Organon (OGN) | United States | $2.605B | 2.77 |
| GeneDx Holdings (WGS) | United States | $2.480B | 95.51 |
| Ardent Health (ARDT) | United States | $2.041B | 8.70 |
| Progyny (PGNY) | United States | $2.024B | 44.55 |
| PACS (PACS) | United States | $1.949B | 0.00 |
| Premier (PINC) | United States | $1.767B | 13.41 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.546B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.329B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.160B | 8.82 |
| CareDx (CDNA) | United States | $1.149B | 17.94 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| Nutex Health (NUTX) | United States | $0.653B | 9.89 |
| Embecta (EMBC) | United States | $0.627B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.567B | 0.00 |
| SBC Medicals (SBC) | United States | $0.552B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.486B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| Omada Health (OMDA) | $0.461B | 0.00 | |
| So-Young (SY) | China | $0.389B | 0.00 |
| Enhabit (EHAB) | United States | $0.375B | 30.88 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.348B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.338B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Oncology Institute (TOI) | United States | $0.256B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Pheton Holdings (PTHL) | China | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |